Large Cap · Healthcare · Medical Devices
Large Cap · Healthcare · Medical Devices
Get the AI take on SYK
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
64/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Lowest
$315
Current price
$342.65
Median target
$382
Highest
$465
Forward P/E
Middle ground · 8% above avg
21.14x
Price / sales
Reasonable · Priced reasonably against its revenue
5.04x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
27.67x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
19.26x
ROIC
Reasonable · A middling return on the capital it puts to work
12.5%
ROE
Middle ground · Mixed
16.5%
Debt / equity
Favorable · 0.66 - strong leverage
0.64x
Current ratio
Strong · Comfortable room to cover bills due within a year
2.16x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $130.11B | 35.1 | +8.5% | 64 | |
| $11.53B | 22.0 | +19.7% | 78 | |
| $4.60B | 13.9 | +13.5% | 77 | |
| $33.87B | 35.4 | +15.5% | 77 | |
| $1.11T | 40.1 | +49.6% | 76 |